Crossref
Compromised quality of medicines: a regulatory failure
Indian Journal of Medical Ethics · 02.05.2026 · 11 (2)
DOI: 10.20529/ijme.2026.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical Ethics, online erschienen am 02.05.2026. Verfasst von Sandhya Srinivasan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Journalist, Bandra West, Mumbai 400 050 INDIA. Hauptthemen laut MEDLINE: Drug Industry, Quality Control.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Drug IndustryQuality ControlHumansIndiaPharmaceutical PreparationsWorld Health OrganizationGuidelines as Topic
Substanzen
Pharmaceutical Preparations
Autor:innen und Institutionen
- Independent Journalist, Bandra West, Mumbai 400 050 INDIA.
- Advocate, Courtyard Attorneys, Worli, Mumbai 400 030 INDIA.
Zitieren
APA
Srinivasan, S., & Johari, V. (2026). Compromised quality of medicines: a regulatory failure. Indian Journal of Medical Ethics, 11(2). https://doi.org/10.20529/ijme.2026.027
Vancouver
Srinivasan S, Johari V. Compromised quality of medicines: a regulatory failure. Indian Journal of Medical Ethics. 2026;11(2). doi:10.20529/ijme.2026.027
BibTeX
@article{Srinivasan2026,
author = {Srinivasan, Sandhya and Johari, Veena},
title = {Compromised quality of medicines: a regulatory failure},
journal = {Indian Journal of Medical Ethics},
year = {2026},
volume = {11},
number = {2},
doi = {10.20529/ijme.2026.027}
}
EUVIMED